Law360, New York (March 25, 2004, 12:00 AM EST) -- A Canadian parliamentary committee will review draft legislation Thursday that could pave the way for Canada to sell generic drugs to fight HIV/AIDS, tuberculosis and malaria to developing countries.
The amendments to the Patent Act and the Food and Drug Act, if passed, would make Canada the first country to act on a World Trade Organization agreement in August for developed nations to allow generics to be sold cheaply to many countries in Africa and Asia.
The WTO's decision aimed to lay to rest a controversy...
Canada Committee Reviews Draft Of Landmark Generics Bill
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
